I believe intelliHR’s SaaS based operational metrics put it in the 75th percentile when compared to global SaaS companies at its current stage (e.g. Sales and Marketing efficiency (Magic Number), Gross Profit Margin (GPM) and Annual Recurring Revenue (ARR) growth), NPS).
Its Annual Recurring Revenue (ARR) has grown from approximately AUD850k to AUD2.36m in the last 12 months (177% Year on Year (YoY) growth) as at 30 June 2020. The company has achieved this growth while achieving cash flow break-even last quarter and maintaining AUD3m in the bank.
This article is a detailed break-down of Botanix Pharmaceuticals (“Botanix”), which listed on the Australian Stock Exchange (ASX) in 2015 under the ticker BOT.
Copyright © Track Record